International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Similar documents
TABLET DESIGN AND FORMULATION

02/09/2016. Roles of Excipients in Pharmaceuticals:

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

Formulation and Evaluation

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

Scholars Research Library

REVISION OF MONOGRAPH ON TABLETS. Tablets

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

Parenteral products-definition

LAB.2. Tablet Production Methods

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

FLORITER. New Technology for Innovative Formulation Design.

Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Etat des travaux du GDP

Critical material properties for the design of robust drug products : excipient functionality related characteristics

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

Easy, fast and reliable!

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

KING KHALID UNIVERSITY

STARCH Application Data

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

Formulation and evaluation of immediate release salbutamol sulphate

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

Formulation and evaluation of oro-dispersible tablets of lafutidine

codex alimentarius commission

Effect of Excipients on Dissolution: Case Studies with Bio-relevant/ Hydro-alcoholic Media

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

3. Drug or plant or excipients profile

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

TEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006.

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

ISSN: Available online Journal of Global Trends in Pharmaceutical Sciences. Research Article

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

Available online through

Available online Research Article

SENTRY TM POLYOX Water Soluble Resins

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

Easy, fast and reliable!

APPLICATION OF ION EXCHANGE RESINS AS TABLET DISINTEGRANTS

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Granulation Aggregation

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Abacavir (as sulfate) 300 mg tablets WHOPAR part 6 May 2016 (Hetero Labs Ltd), HA575

Challenges and solutions for moisture sensitive API formulation

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX

Multifunctional Excipients: The Smart Excipients

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION

FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL

This PDF is available for free download from a site hosted by Medknow Publications

Wettable Magnesium Stearate. What Are Customers Looking for in Selecting Pharmaceutical Lubricants?

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

DISSOLUTION ENHANCEMENT OF CARVEDILOL BY USING SURFACTANT AS A COATING MATERIAL

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

Design and development of fast Melting Tablets of Terbutaline Sulphate

Asian Journal of Research in Biological and Pharmaceutical Sciences

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Journal of Chemical and Pharmaceutical Research

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Biswajit Biswal IRJP 2 (7)

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

Rationale of and Experience with the Expert System

Optimization of valsartan tablet formulation by 2 3 factorial design

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

Transcription:

Research Article CODEX: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON PHARMACEUTICAL EXCIPIENTS Prasad Telaprolu 1*, M. Venkata Anjaneyulu 1, Y. Nagarjuna reddy 2 1* Department of Pharmaceutics, Narasaraopet Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India. 2 Department of Pharmaceutics, Siddhartha Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India. ABSTRACT In addition to transporting the active drug to the site in the body where the drug is intended to exert its action, excipients play an important part in the manufacturing process. They may also be important for keeping the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric irritation or stomach upset. In this review we discussed about all the excipients used in the pharmaceutical formulations. KEYWORDS Excipients, Active drug, Tissue, Gastric upset and Formulation. Author for Correspondence: Prasad. Telaprolu, Department of Pharmaceutics, Narasaraopet Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India. Email: prasadpharma123@gmail.com INTRODUCTION Pharmaceutical excipient means any component other than the pharmacologically active drug which is included in the manufacturing process or is contained in a finished pharmaceutical product dosage form. While selecting excipients for any formulation following things should be considered wherever possible: keep the excipients to a minimum in number minimize the quantity of each excipients and multifunctional excipients may be given preference over unifunctional excipients. Fewer ingredients in the formulation are better for the following reasons. Available online: www.uptodateresearchpublication.com July - August 423

1. Excipients are not completely inert. Even commonly used excipients that are deemed to be pharmaceutically inactive and nontoxic may cause adverse reactions 2. Less ingredient variability to influence process and product consistency 3. Better economic efficiency in product manufacturing 4. Less probability of chemical or physical interaction between API and excipients and among excipients. Excipients play a crucial role in design of the delivery system, determining its quality and performance. Excipients though usually regarded as nontoxic there are examples of known excipient induced toxicities which include renal failure and death from diethylene glycol, osmotic diarrhoea caused by ingested mannitol, hypersensitivity reactions from lanolin and cardiotoxicity induced by propylene glycol. Excipients may also be important for keeping the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric discomfort or stomach upset. Excipient Grades 1,2 Many excipients for pharmaceutical use are available in different grades. These grades are differentiated frequently by means of physical and chemical characteristics. The reason for grades is to change the performance characteristics of excipients. Excipients are chosen in tablet formulation to perform a variety of functions like 1. For providing essential manufacturing technology functions (binders, glidants, lubricants may be added) 2. For enhancing patient acceptance (flavors, colourants may be added) 3. For providing aid in product identification (colourants may be added) 4. For Optimizing or modifying drug release (disintegrants, hydrophilic polymers, wetting agents, biodegradable polymers may be added) 5. For enhancing stability (antioxidant, UV absorbers may be added). Table No.1: Provides different types of excipients used in pharmaceuticals 3-10. Diluents (Fillers) In order to facilitate tablet handling during manufacture and to achieve targeted content uniformity, the tablet size should be kept above 2-3 mm and weight of tablet above 50 mg. usually the range of diluent may vary from 5-80%. Diluents are also synonymously known as fillers. Diluents are often added to tablet formulations for secondary reasons like to provide better tablet properties such as: 1. To provide improved cohesion 2. To allow direct compression manufacturing 3. To enhance flow 4. To adjust weight of tablet as per die capacity Classification of diluents Tablet diluents or fillers can be divided into following categories: Organic materials Carbohydrate and modified carbohydrates. Examples Powdered cellulose, Microcrystalline cellulose (MCC), Starch, Starch 1500 (Pregelatinized Starch), Lactose, Sucrose, Mannitol and Sorbitol. Inorganic materials Calcium phosphates and others. Co-processed Diluents Tablet diluent or filler may also be classified on the basis of their solubility in water as soluble and insoluble shown in Table No.2. Selection of diluent Should be done after considering properties of diluent such as: Compactibility, Flowability, Solubility, Disintegration qualities, Hygroscopicity, Lubricity and Stab. Co-processed diluents Co-processing means combining two or more materials by an appropriate process. The products so formed are physically modified in such a special way that they do not loose their chemical structure and stability. Now a day s direct compression Available online: www.uptodateresearchpublication.com July - August 424

technique has been one of the well-accepted methods of tablet manufacture. Binders Binders act as an adhesive to bind together powders, granules and tablets to result in the necessary mechanical strength: 1. As a dry powder with other excipients in dry granulation (roller compaction, slugging) or as an extra-granular excipient in a wet granulation tablet formulation. 2. As a dry powder with other intra-granular excipients in wet granulation. When the granulating fluid is added, the binder may dissolve partially or completely to then exhibit adhesive binding properties in helping granules to form. 3. Most commonly in wet granulation, the binder is added already dissolved in the granulating fluid to enable a more effective and controllable granule formation. 4. Water is the most common granulating fluid, very occasionally in a co-solvent system with, e.g. ethanol. 1. Dry binders: Pregelatinised starch, cross-linked PVP 2. Solution binders: HPMC, PVP 3. Soluble in water/ethanol mix: PVP. Disintegrants Disintegrants, an important excipient of the tablet formulation, are always added to tablet to induce breakup of tablet when it comes in contact with aqueous fluid and this process of desegregation of constituent particles before the drug dissolution occurs, is known as disintegration process and excipients which induce this process are known as disintegrants. The objectives behind addition of disintegrants are to increase surface area of the tablet fragments and to overcome cohesive forces that keep particles together in a tablet. Different types of disintegrants shown in Table No.3. Superdisintegrants As day s passes, demand for faster disintegrating formulation is increased. So, pharmacist needs to formulate disintegrants i.e. Superdisintegrants which are effective at low concentration and have greater disintegrating efficiency and they are more effective intragranularly. But have one drawback that it is hygroscopic therefore not used with moisture sensitive drugs. Table No.4 contains different types of super disintegrants. Antiadherents Some material have strong adhesive properties towards the metal of punches and dies or the tablet formulation containing excessive moisture which has tendency to result in picking and sticking problem. Therefore, antiadherents or anti-sticking agents prevent adhesion of the tablet surface to the die walls and the punches. Talc, magnesium stearate and corn starch have excellent antiadherent properties. Vegan had suggested that silicon oil can be used as antiadherent. (Different types of antiadherents shown in Table No.5). Glidants Glidants are added to the formulation to improve the flow properties of the material which is to be fed into the die cavity and aid in particle rearrangement within the die during the early stages of compression. If the flow properties are extremely poor then glidants are ineffective and consideration of force free mechanisms may be necessary. The effect of glidants on the flow of the granules depends on the shape and size of the particle of the glidant and the the granule. The commonly used glidants are talcum, starch, colloidal silica silicates, stearates calcium phosphate, etc. Wetting Agents Wetting Agents in tablet formulation aid water uptake and thereby enhancing disintegration and assisting in drug dissolution. Incorporation of anionic surfactant like Sodium Lauryl Sulphate (SLS) is known to enhance the dissolution. It has been established that SLS improves permeation of drug through biological membrane since it destroys the path through which drug has to pass and thus minimizing the path length for the drug to travel. Available online: www.uptodateresearchpublication.com July - August 425

Wetting agents are mainly added when hydrophobic drug is to be formulated into tablet. SLS, Sodium diisobutyl sulfosuccinate are used as wetting agent in tablet formulation. Dissolution Retardants Dissolution Retardants are incorporated into tablet formulation only when controlled release of drug is required. Waxy materials like stearic acid and their esters can be used as dissolution retardants. Dissolution Enhancers They are the agents that alter the molecular forces between ingredients to enhance the dissolution of solute in the solvent. Fructose, Povidone, Surfactants are used as dissolution enhancer. Adsorbents Adsorbents are the agents that can retain large quantities of liquids. Therefore liquids like Vitamin E can be incorporated into tablets by addition of adsorbents. Most commonly used adsorbents in pharmaceuticals are anhydrous calcium phosphate, starch, magnesium carbonate, bentonite, kaolin, magnesium silicate, magnesium oxide and silicon dioxide. Buffers Buffers are added to maintain a required ph since a change in ph may cause significant alteration in stability. Most commonly used buffering agent in tablet formulation includes sodium bicarbonate, calcium carbonate, and sodium citrate. Antioxidants Antioxidants are added in tablet formulation to protect drug from undergoing oxidation. Antioxidants undergo oxidation in place of drug or they block the oxidation reaction or they act as synergists to other antioxidants. Chelators may also act as antioxidant. Most commonly used antioxidants include ascorbic acid and their esters, alpha-tocopherol, ethylene diamine tetra acetic acid, sodium metabisulfite, sodium bisulfite, Butylated Hydroxy Toluene (BHT), Butylated Hydroxy Anisole (BHA), citric acid and tartaric acid. Chelating Agents Chelating agents tend to form complexes with trace amount of heavy metal ions inactivating their catalytic activity in the oxidation of medicaments. Ethylenediamine tetracetic acid and its salts, Dihydroxy Ethyl Glycine, Citric Acid and Tartaric Acid are most commonly used chelators. Preservatives Preservatives may be a part of tablet formulation in order to prevent the growth of microorganisms in tablet formulation. Parabens like methyl, propyl, benzyl, butyl p- hydroxy benzoate are used as preservatives. Colorants Colorants neither contribute to therapeutic activity nor do they improve product bioavailability or stability but are incorporated into tablets for purposes like to facilitate identification of similar looking products with in a product line to avoid mix ups, to facilitate identification of products of similar appearance that exist in the lines of different manufacturers, to overcome colour change on aging, disguising of off-colour drugs, for brand image in the market, to enhance the aesthetic appearance of the product to have better patient acceptance. Some Commonly Used Pharmaceutical Colorants shown in Table No.6. Flavours Flavors are commonly used to improve the taste of chewable tablets as well as mouth dissolved tablets. Flavors are incorporated either as solids (spray dried flavors) or oils or aqueous (water soluble) flavors. Sweeteners Sweeteners are added primarily to chewable tablets. Table No.7 shows different types of pharmaceutical sweeteners). Available online: www.uptodateresearchpublication.com July - August 426

Table No.1: Excipients Used in Tablet Formulation S.No Excipients Function 1 Diluents or Fillers Diluents make the required bulk of the tablet when the drug dosage itself is inadequate to produce tablets of adequate weight and size. 2 Binders or Binders add cohesiveness to powders, thus providing the necessary bonding to form Granulating agents granules, which under compaction form a cohesive mass or a compact which is referred to or Adhesives as a tablet. 3 Disintegrants Disintegrant is added to facilitate a breakup or disintegration of the tablet when placed in an aqueous environment. Antifrictional Agents 4 Lubricants Lubricants are intended to reduce the friction during tablet formation in a die and also during ejection from die cavity. 5 Antiadherents Antiadherents reduce sticking or adhesion of any of the tablet granulation or powder to the faces of the punches or to the die wall. 6 Glidants Glidants promote the flow of tablet granulation or powder mixture from hopper to the die cavity by reducing friction between the particles. Miscellaneous 7 Wetting agents Wetting agents are added to tablet formulation to aid water uptake during disintegration and assist drug dissolution. 8 Dissolution Dissolution retardants as the name suggest, retards the dissolution of active pharmaceutical 9 retardants Dissolution enhancers 10 Adsorbents ingredient(s). Dissolution enhancers as the name suggest, enhance the dissolution rate of active pharmaceutical ingredient(s). Adsorbents are capable of retaining large quantities of liquids without becoming wet; this property of absorbent allows many oils, fluid extracts and eutectic melts to be incorporated into tablets. 11 Buffers Buffers are added to provide suitable micro environmental ph to get improved stability and / or bioavailability. 12 Antioxidants Antioxidants are added to maintain product stability, they act by being preferentially oxidized and gradually consumed over shelf life of the product. 13 Chelating agents Chelating agents are added to protect against autoxidation; they act by forming complexes with the heavy metal ions which are often required to initiate oxidative reactions. 14 Preservatives Preservatives are added to tablet formulation in order to prevent the growth of microorganisms. 15 Colours Colours are added to tablet formulation for following purposes: to disguise off colour drugs, product identification and for production of more elegant product. 16 Flavours Flavours are added to tablet formulation in order to make them palatable enough in case of chewable tablet by improving the taste. 17 Sweeteners Sweeteners are added to tablet formulation to improve the taste of chewable tablets. Available online: www.uptodateresearchpublication.com July - August 427

Table No.2: Types of Diluents S.No Insoluble Tablet Diluents Soluble Tablet Diluents Starch Powdered Lactose 1 cellulose Sucrose Microcrystalline Mannitol cellulose Sorbitol etc. Calcium phosphates etc. Table No.3: List of Disintegrants S.No Disintegrants Concentration in granules (%w/w) Special comments 1 Starch USP 5-20 Higher amount is required, poorly compressible 2 Starch 1500 5-15 - 3 Avicel (PH 101 & 102) 10-20 Lubricant properties and directly compressible 4 Solka floc 5-15 Purified wood cellulose 5 Alginic acid 1-5 Acts by swelling 6 Na alginate 2.5-10 Acts by swelling 7 Explotab 2-8 Sodium starch glycolate, superdisintegrant. 8 Polyplasdone (XL) 0.5-5 Crosslinked PVP 9 Amberlite (IPR 88) 0.5-5 Ion exchange resin 10 MC, Na-CMC & HPMC 5-10 - 11 AC-Di-Sol 1-3 Direct compression 2-4 Wet granulation 12 Carbon dioxide _ Created insitu in effervescent tablet Available online: www.uptodateresearchpublication.com July - August 428

Table No.4: List of Superdisintegrants S.No Superdisintegrants Example of Superdisintegrants Mechanism of action Special Comment Crosscarmellose Ac-Di-Sol 1 Nymce ZSX Primellose Solutab Vivasol Crosspovidone 2 Crosspovidon M Kollidon Polyplasdone Sodium starch glycolate 3 Explotab Primogel 4 Alginic acid NF Satialgine Soy polysaccharides 5 Emcosoy -Swells 4-8 folds in < 10 seconds. Crosslinked cellulose -Swelling and wicking both. Swells very little and returns to original size Crosslinked PVP after compression but act by capillary action Swells 7-12 folds in <30 Crosslinked starch seconds Rapid swelling in Crosslinked alginic acid aqueous medium or wicking action Natural super disintegrant --- Swells in two dimensions. Direct compression or granulation. Starch free Water insoluble and spongy in nature so get porous tablet Swells in three dimensions and high level serve as sustain release matrix Promote disintegration in both dry or wet granulation Does not contain any starch or sugar. Used in nutritional products. Available online: www.uptodateresearchpublication.com July - August 429

Table No.5: List of Antiadherents S.No Antiadherent Concentration Range (%w/w) Comments 1 Talc 1-5 Lubricant with excellent antiadherents properties 2 Corn starch 3-10 Lubricant with excellent antiadherents properties 3 Colloidal silica 0.1-0.5 Does not give satisfactory results due to small surface area. Cab-O-Sil and Syloid 4 DL-Leucine 3-10 Water soluble lubricant; excellent antiadherents properties 5 Sodium Lauryl Sulfate less than 1 Antiadherents with water soluble lubricant 6 Stearates less than 1 Antiadherents with water insoluble lubricant Table No.6: Some Commonly Used Pharmaceutical Colorants (Synthetic) S.No FD & C Colour Common Name 1 Red 3 Erythrosine 2 Red 40 Allura red AC 3 Yellow 5 Tartrazine 4 Yellow 6 Sunset Yellow 5 Blue 1 Brilliant Blue 6 Blue 2 Indigotine 7 Green 3 Fast Green Table No.7: Some of the Sweeteners Used in Tablet Formulation S.No Natural Sweeteners Artificial Sweeteners 1 Mannitol Saccharin 2 Lactose Cyclamate 3 Sucrose Aspartame Available online: www.uptodateresearchpublication.com July - August 430

CONCLUSION Excipients are the most important field of pharmaceutical formulation which needs deep study to evaluate new formulation with different concentrations of different pharmaceutical aids. ACKNOWLEDGEMENT The authors are sincerely thanks to the Narasaraopet Institute of Pharmaceutical Sciences, Narasaraopet, Guntur, Andhra Pradesh, India for providing the facilities to complete this review work. CONFLICT OF INTEREST We declare that we have no conflict of interest. REFERENCES 1. Lachman L, Liberman H and Kanig J. The Theory and Practice of Industrial Pharmacy, Varghese publication house, 3 rd edition, 2009, 293-345, 346-373. 2. Aulton M. Pharmaceutics: The Science of Dosage Form Design, International Student Edition, 1, 2002, 304-321, 347-668. 3. Lachman L, Liberman L and Schwartz J. Pharmaceutical Dosage Forms: Tablets, CRC Press, 2 nd edition, 1, 1989. 4. Remington J, Remington. The Science and Practice of Pharmacy, 9 th edition, 2, 1945, 1615-1641. 5. Banker G and Rhodes C. Drug and Pharmaceutical Sciences: Modern Pharmaceutics, Marcel Dekker Inc, New York, 3 rd edition, 72, 1999, 333-394. 6. Martin E. Dispensing of Medication, Mack Publishing Co, 7 th edition, 2006, 740-741. 7. Lachman L, Liberman L and Schwartz J. Pharmaceutical Dosage Forms: Tablets, CRC Press, 2 nd edition, 2, 1989, 304-321. 8. Indian Pharmacopoeia, 4 th edition, 1and 2, 1996. 9. British Pharmacopoeia, 1, 2001, 1481-1482. 10. The United State Pharmacopoeia 24, The National Formulary, 19(8), 2000, 182-3. Please cite this article in press as: Prasad Telaprolu. et al. A review on pharmaceutical excipients, International Journal of Research in Pharmaceutical and Nano Sciences, 2(4), 2013, 423-431. Available online: www.uptodateresearchpublication.com July - August 431